4.8 Article

Polymersome delivery of siRNA and antisense oligonucleotides

Journal

JOURNAL OF CONTROLLED RELEASE
Volume 134, Issue 2, Pages 132-140

Publisher

ELSEVIER
DOI: 10.1016/j.jconrel.2008.10.020

Keywords

Polymersome; siRNA; AON; Antisense; Exon skipping; Muscular dystrophy

Funding

  1. NIH-NIBIB/NIAMS
  2. MDA
  3. NSF
  4. Penn-Drexel NTI

Ask authors/readers for more resources

siRNA and antisense oligonucleotides, AON, have similar size and negative charge and are often packaged for in vitro delivery with cationic lipids or polymers-but exposed positive charge is problematic in vivo. Here we demonstrate loading and functional delivery of RNAi and AON with non-ionic, nano-transforming polymersomes. These degradable carriers are taken up passively by cultured cells after which the vesicles transform into micelles that allow endolysosomal escape and delivery of either siRNA into cytosol for mRNA knockdown or else AON into the nucleus for exon skipping within pre-mRNA. Polymersome-mediated knockdown appears as efficient as common cationic-lipid transfection and about half as effective as Lentivirus after sustained selection. For AON, initial results also show that intramuscular injection into a mouse model of muscular dystrophy leads to the expected protein expression, which occurs along the entire length of muscle. The lack of cationic groups in antisense polymersomes together with initial tests of efficacy suggests broader utility of these non-viral carriers. (C) 2008 Elsevier B.V. All rights reserved.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.8
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available